Automated Cell Processing System Market Extensive Industry Analysis, Growth Rate, Segmentation, Investment Opportunities and Top Manufacturers 2035

Automation Is Helping Cell Therapy Manufacturers Improve Consistency and Scalability

Cell therapies involve complex manufacturing workflows that can include cell collection, separation, expansion, harvesting, formulation, filling and cryopreservation. As more therapies move into clinical and commercial development, manufacturers are looking for ways to automate these processes.

The automated cell processing systems market was estimated at approximately USD 220 million in 2020 and is expected to grow at a CAGR of around 16% through 2030.

Automation can reduce manual intervention and improve process reproducibility. Closed systems can also help limit contamination risks while supporting traceability.

More than 60 automated and closed systems are currently captured across processing steps such as apheresis, separation, expansion, harvest, fill-finish, cryopreservation and thawing.

Cell and gene therapy manufacturers are increasingly interested in scalable systems that can support both clinical and commercial production.

Data management is another important feature. Automated platforms can record process parameters, track materials and support regulatory documentation.

Companies such as Cytiva, Pall, Terumo BCT and ThermoGenesis are among the providers captured in the market landscape.

As cell therapies become more complex and manufacturing volumes increase, automation could become essential for reducing variability and improving operational efficiency.

For more information on the Automated Cell Processing Systems Market, visit:

https://www.rootsanalysis.com/reports/cell-therapy-processing-systems-market.html